日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release

非对称抗 CLL-1×CD3 双特异性抗体 ABL602 2+1 具有减弱的 CD3 亲和力,具有强大的抗肿瘤活性,但细胞因子释放有限

Eunhee Lee, Shinai Lee, Sumyeong Park, Yong-Gyu Son, Jiseon Yoo, Youngil Koh, Dong-Yeop Shin, Yangmi Lim, Jonghwa Won

Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade

新型抗4-1BB×PD-L1双特异性抗体通过肿瘤导向的T细胞活化和检查点阻断增强抗肿瘤免疫力

Seongju Jeong ,Eunyoung Park ,Hyung-Don Kim ,Eunsil Sung ,Hyunjoo Kim ,Jaehyoung Jeon ,Youngkwang Kim ,Ui-Jung Jung ,Yong-Gyu Son ,Youngeun Hong ,Hanbyul Lee ,Shinai Lee ,Yangmi Lim ,Jonghwa Won ,Minwoo Jeon ,Shin Hwang ,Lei Fang ,Wenqing Jiang ,Zhengyi Wang ,Eui-Cheol Shin ,Su-Hyung Park ,Jaeho Jung

Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts

新型抗 EGFR 抗体 GC1118 对患者来源异种移植中具有高 EGFR 扩增的胶质母细胞瘤的治疗效果

Kyoungmin Lee, Harim Koo, Yejin Kim, Donggeon Kim, Eunju Son, Heekyoung Yang, Yangmi Lim, Minkyu Hur, Hye Won Lee, Seung Won Choi, Do-Hyun Nam

Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts

抗 EGFR 抗体 GC1118 对 KRAS 突变驱动的结肠直肠癌患者异种移植具有良好的治疗效果

Hye Won Lee, Eunju Son, Kyoungmin Lee, Yeri Lee, Yejin Kim, Jae-Chul Lee, Yangmi Lim, Minkyu Hur, Donggeon Kim, Do-Hyun Nam

A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells

FAK-p120RasGAP-p190RhoGAP 复合物调节迁移细胞的极性

Alok Tomar, Ssang-Taek Lim, Yangmi Lim, David D Schlaepfer

PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility

PyK2 和 FAK 与 p190Rho 鸟嘌呤核苷酸交换因子的连接调节 RhoA 活性、粘着斑形成和细胞运动

Yangmi Lim, Ssang-Taek Lim, Alok Tomar, Margaret Gardel, Joie A Bernard-Trifilo, Xiao Lei Chen, Sean A Uryu, Rafaela Canete-Soler, Jinbin Zhai, Hong Lin, William W Schlaepfer, Perihan Nalbant, Gary Bokoch, Dusko Ilic, Clare Waterman-Storer, David D Schlaepfer